Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey

Aims/hypothesisCardiac autonomic nervous dysfunction (CAND) raises the risk of mortality, but the glycaemic threshold at which it develops is unclear. We aimed to determine the prevalence of, risk factors for and impact of CAND in glucose intolerance and diabetes.MethodsAmong 1,332 eligible participants aged 55–74 years in the population-based cross-sectional KORA S4 study, 130 had known diabetes mellitus (k-DM), and the remaining 1,202 underwent an OGTT. Heart rate variability (HRV) and QT variability were computed from supine 5 min ECGs.ResultsIn all, 565 individuals had normal glucose tolerance (NGT), 336 had isolated impaired fasting glucose (i-IFG), 72 had isolated impaired glucose tolerance (i-IGT), 151 had combined IFG–IGT (IFG–IGT) and 78 had newly detected diabetes mellitus (n-DM). Adjusted normal HRV limits were defined in the NGT population (5th and 95th percentiles). Three HRV measures were more frequently abnormal in those with k-DM, n-DM, IFG–IGT and i-IFG than in those with NGT (p < 0.05). The rates of CAND (≥2 of 4 HRV indices abnormal) were: NGT, 4.5%; i-IFG, 8.1%; i-IGT, 5.9%; IFG–IGT, 11.4%; n-DM, 11.7%; and k-DM, 17.5% (p < 0.05 vs NGT, except for i-IGT). Reduced HRV was associated with cardiovascular risk factors used to construct a simple screening score for CAND. Mortality was higher in participants with reduced HRV (p < 0.05 vs normal HRV).Conclusions/interpretationIn the general population aged 55–74 years, the prevalence of CAND is increased not only in individuals with diabetes, but also in those with IFG–IGT and, to a lesser degree, in those with i-IFG. It is associated with mortality and modifiable cardiovascular risk factors which may be used to screen for diminished HRV in clinical practice.

[1]  S. Tesfaye,et al.  Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[2]  Zihui Tang,et al.  A Simple Chinese Risk Score Model for Screening Cardiovascular Autonomic Neuropathy , 2014, PloS one.

[3]  J. Kurths,et al.  Nonlinear analysis of complex phenomena in cardiological data , 2000, Herzschrittmachertherapie und Elektrophysiologie.

[4]  P. Wahl,et al.  Prevalence of Complications Among Second-Generation Japanese-American Men With Diabetes, Impaired Glucose Tolerance, or Normal Glucose Tolerance , 1987, Diabetes.

[5]  J. Tuomilehto,et al.  Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. , 2002, European heart journal.

[6]  H. Calkins,et al.  Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. , 1997, Circulation.

[7]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[8]  J. Shaw,et al.  Epidemiology of polyneuropathy in diabetes and prediabetes. , 2014, Handbook of clinical neurology.

[9]  Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[10]  R. Kronmal,et al.  The relationship of heart rate and heart rate variability to non‐diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[11]  A. Perciaccante,et al.  Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus , 2006, BMC cardiovascular disorders.

[12]  A Voss,et al.  Short-term heart rate variability—age dependence in healthy subjects , 2012, Physiological measurement.

[13]  Jeroen J. Bax,et al.  ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration , 2014 .

[14]  A Schirdewan,et al.  Forecasting of Life Threatening Arrhythmias Using the Compression Entropy of Heart Rate , 2004, Methods of Information in Medicine.

[15]  B. Hoogwerf,et al.  Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. , 2002, Diabetes.

[16]  A. Vinik,et al.  Neuropathy in prediabetes: does the clock start ticking early? , 2011, Nature Reviews Endocrinology.

[17]  O. Melander,et al.  Soluble Urokinase Plasminogen Activator Receptor: A Risk Factor for Carotid Plaque, Stroke, and Coronary Artery Disease , 2014, Stroke.

[18]  Matteo Anselmino,et al.  Diabetes, prediabetes and cardiovascular risk , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[19]  T. Tanridag,et al.  Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance , 2008, Diabetes/metabolism research and reviews.

[20]  Richard A. Johnson,et al.  A new family of power transformations to improve normality or symmetry , 2000 .

[21]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[22]  W. Rathmann,et al.  Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population , 2008, Diabetes Care.

[23]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[24]  A. Antonelli,et al.  Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Jagmeet P. Singh,et al.  Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). , 2000, The American journal of cardiology.

[26]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[27]  Antti M Kiviniemi,et al.  Heart rate variability and the metabolic syndrome: a systematic review of the literature , 2014, Diabetes/metabolism research and reviews.

[28]  W. Rathmann,et al.  Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[29]  L. Chambless,et al.  Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. , 2005, Diabetes care.

[30]  Pere Caminal,et al.  Methods derived from nonlinear dynamics for analysing heart rate variability , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[31]  Chih-Hsing Wu,et al.  Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. , 2007, The Journal of clinical endocrinology and metabolism.

[32]  H. Löwel,et al.  High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000 , 2003, Diabetologia.

[33]  T. Chen,et al.  Prevalence and Risk Factors of Somatic and Autonomic Neuropathy in Prediabetic and Diabetic Patients , 2009, Neuroepidemiology.

[34]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[35]  P. Kumarathurai,et al.  Soluble urokinase plasminogen activator receptor, C‐reactive protein and triglyceride are associated with heart rate variability in non‐diabetic Danes , 2013, European journal of clinical investigation.

[36]  A. Voss,et al.  Blood Pressure Variability as Sign of Autonomic Imbalance in Patients with Idiopathic Dilated Cardiomyopathy , 2012, Pacing and clinical electrophysiology : PACE.

[37]  K. Khunti,et al.  Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis , 2013, Diabetologia.

[38]  R. Heethaar,et al.  Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study , 2000, Diabetologia.

[39]  J. Eriksson,et al.  Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[40]  B. Stricker,et al.  Short-term QT variability markers for the prediction of ventricular arrhythmias and sudden cardiac death: a systematic review , 2014, Heart.

[41]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[42]  Mark E Molitch,et al.  The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.

[43]  M. Haigney,et al.  QT Variability Index. , 2013, Progress in cardiovascular diseases.

[44]  J. Tuomilehto,et al.  Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range , 2010, Diabetes Care.

[45]  S. Subramanian,et al.  Association between Cardiac Autonomic Function, Oxidative Stress and Inflammatory Response in Impaired Fasting Glucose Subjects: Cross-Sectional Study , 2012, PloS one.

[46]  Pere Caminal,et al.  Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification , 2013, Frontiers in Physiology.

[47]  Andreas Voss,et al.  Influence of age and gender on complexity measures for short term heart rate variability analysis in healthy subjects , 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[48]  D. Williamson,et al.  Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010–2030 , 2013, Population Health Metrics.

[49]  R. Petrella,et al.  Diabetes and Technology for Increased Activity Study: The Effects of Exercise and Technology on Heart Rate Variability and Metabolic Syndrome Risk Factors , 2013, Front. Endocrinol..